Product Information
BLEOMYCIN SULFATE 15 UNIT VIAL is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $26.4480 per EA under NDC 00143924001. Its NADAC has been published 88 times since Dec 18, 2024.
FDA first approved this application on Oct 17, 2001. Its Orange Book therapeutic-equivalence code is AP.
Strength
15 [USP'U]/1
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00143924001
Classification
Generic
Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAMUSCULAR; INTRAPLEURAL; INTRAVENOUS; SUBCUTANEOUS
Effective Date
4/22/2026
Active Ingredients
BLEOMYCIN SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA065042FDA Approved
10/17/2001
TE Code
AP
On Market Since
1/9/2018
Pharmacological Classes
Price Statistics
The NADAC for BLEOMYCIN SULFATE 15 UNIT VIAL has been published 88 times since Dec 18, 2024, and over the history we have for it it has declined 16.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $26.4480 per EA |
|---|---|
| All-time high | $31.7820 (Dec 10, 2025) |
| All-time low | $24.0040 (Dec 17, 2025) |
| 52-week high | $31.7820 |
| 52-week low | $24.0040 |
| Median price | $31.7820 |
| Average price | $29.2065 |
| Largest weekly change | -24.5% (Dec 17, 2025) |
| Weeks tracked | 88 |
| Tracking since | Dec 18, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Bleomycin market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BLEOMYCIN SULFATE 15 UNIT VIAL?
The current National Average Drug Acquisition Cost (NADAC) for BLEOMYCIN SULFATE 15 UNIT VIAL, manufactured by Hikma Pharmaceuticals USA Inc., is $26.4480 per EA (NDC 00143924001), effective Aug 19, 2026.
How has the price of BLEOMYCIN SULFATE 15 UNIT VIAL changed over time?
Over the history we have for it, the NADAC for BLEOMYCIN SULFATE 15 UNIT VIAL has declined 16.8%. It has been tracked across 88 weekly CMS publications since Dec 18, 2024.
What are the highest and lowest recorded NADAC prices for BLEOMYCIN SULFATE 15 UNIT VIAL?
Since Dec 18, 2024, the NADAC for BLEOMYCIN SULFATE 15 UNIT VIAL has ranged from a low of $24.0040 (Dec 17, 2025) to a high of $31.7820 (Dec 10, 2025), with a median of $31.7820 per EA.
Are there cheaper alternatives to BLEOMYCIN SULFATE 15 UNIT VIAL?
No other NADAC-published product currently shares the active ingredient and strength of BLEOMYCIN SULFATE 15 UNIT VIAL in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures BLEOMYCIN SULFATE 15 UNIT VIAL?
BLEOMYCIN SULFATE 15 UNIT VIAL (NDC 00143924001) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.